Baseline serum matrix metalloproteinase-9 level predicts long-term prognosis after coronary revascularizations in stable coronary artery disease

Zhong Xuan Ye, Hsin Bang Leu, Tao Cheng Wu, Shing Jong Lin, Jaw Wen Chen

研究成果: 雜誌貢獻文章

14 引文 斯高帕斯(Scopus)

摘要

Objectives: This study aimed to investigate whether baseline serum levels of matrix metalloproteinases (MMPs) could predict long-term prognosis of coronary revascularizations. Designs and methods: Ninety-one consecutive patients receiving coronary revascularizations (58 percutaneous coronary interventions and 33 coronary artery bypass graft surgeries) for stable coronary artery disease (CAD) were studied. Baseline serum levels of high-sensitive C-reactive protein (hsCRP), MMP-2, -3 and -9 drawn before revascularization were correlated to the clinical adverse events within > 12 months after revascularizations. Results: Baseline characteristics were similar between the two groups. There were total 22 major adverse cardiovascular events during a mean period of 27 months. Only baseline serum MMP-9 level independently predicted future cardiovascular events after coronary revascularization either by multivariate analysis (relative risk 3.18, p = 0.028) or by Kaplan-Meier analysis (p = 0.021). Conclusions: Baseline serum MMP-9 level predicted the prognosis after coronary revascularizations, suggesting its potential role in risk stratification before revascularization strategies for stable CAD.

原文英語
頁(從 - 到)292-298
頁數7
期刊Clinical Biochemistry
41
發行號4-5
DOIs
出版狀態已發佈 - 三月 2008

ASJC Scopus subject areas

  • Clinical Biochemistry

指紋 深入研究「Baseline serum matrix metalloproteinase-9 level predicts long-term prognosis after coronary revascularizations in stable coronary artery disease」主題。共同形成了獨特的指紋。

  • 引用此